This document outlines an exclusive GP-led secondary deal for Project Klein, expected to close in June 2018. The deal involves a mid-market buyout strategy focusing on four companies in Europe/UK, primarily in business and healthcare services. Key investment data includes an invested capital of €60-100m, a discount to NAV of over 5%, and a gross multiple of 1.1x. The investment rationale highlights the potential for growth due to industry changes and cost efficiency initiatives.
documents/EFTA01390959.pdf
{}